Transamerica Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Sell |
5,646
-86
| -2% | -$7.13K | 0.04% | 191 |
|
|
2025
Q1 | $465K | Buy |
5,732
+267
| +5% | +$21.7K | 0.05% | 191 |
|
|
2024
Q4 | $493K | Sell |
5,465
-1,532
| -22% | -$138K | 0.05% | 190 |
|
|
2024
Q3 | $692K | Sell |
6,997
-973
| -12% | -$96.2K | 0.07% | 179 |
|
|
2024
Q2 | $739K | Hold |
7,970
| – | – | 0.08% | 157 |
|
|
2024
Q1 | $757K | Sell |
7,970
-1,652
| -17% | -$157K | 0.08% | 174 |
|
|
2023
Q4 | $860K | Sell |
9,622
-5,715
| -37% | -$511K | 0.12% | 129 |
|
|
2023
Q3 | $1.12M | Buy |
15,337
+1,402
| +10% | +$102K | 0.15% | 113 |
|
|
2023
Q2 | $1.16M | Buy |
13,935
+5,333
| +62% | +$444K | 0.15% | 120 |
|
|
2023
Q1 | $656K | Buy |
8,602
+385
| +5% | +$29.4K | 0.09% | 155 |
|
|
2022
Q4 | $682K | Buy |
+8,217
| New | +$682K | 0.1% | 153 |
|
|
2016
Q2 | – | Sell |
-244
| Closed | -$13K | – | 708 |
|
|
2016
Q1 | $13K | Buy |
244
+19
| +8% | +$1.01K | ﹤0.01% | 522 |
|
|
2015
Q4 | $16K | Hold |
225
| – | – | ﹤0.01% | 551 |
|
|
2015
Q3 | $15K | Buy |
+225
| New | +$15K | ﹤0.01% | 535 |
|